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Abstract
Objective: Systematically review and Grading of Recommendations Assessment, Development, and Evaluation (GRADE) studies
on prophylactic negative pressure wound therapy (pNPWT) to prevent surgical site infections (SSIs).
Introduction: pNPWT has been suggested as a new method to prevent wound complications, speciﬁcally SSIs, by its application
on closed incisional wounds.
Methods: This review was conducted as part of the development of the Global Guidelines for prevention of SSIs commissioned by
World Health Organization in Geneva. PubMed, Embase, CENTRAL, CINAHL, and theWorld Health Organization database between
January 1, 1990 and October 7, 2015 were searched. Inclusion criteria were randomized controlled trials and observational studies
comparing pNPWT with conventional wound dressings and reporting on the incidence of SSI. Meta-analyses were performed with a
random effect model. GRADE Pro software was used to qualify the evidence.
Results:Nineteen articles describing 21 studies (6 randomized controlled trials and 15 observational) were included in the review.
Summary estimate showed a signiﬁcant beneﬁt of pNPWT over conventional wound dressings in reducing SSIs in both randomized
controlled trials and observational studies, odds ratio of 0.56 (95% conﬁdence interval, 0.32–0.96; P=0.04) and odds ratio of 0.30
(95% conﬁdence interval, 0.22–0.42; P<0.00001), respectively. This translates into lowering the SSI rate from 140 to 83 (49–135)
per 1000 patients and from 106 to 34 (25–47) per 1000 patients, respectively. In stratiﬁed analyses, these results were consistent in
both clean and clean-contaminated procedures and in different types of surgery, however results were no longer signiﬁcant for
orthopaedic/trauma surgery. The level of evidence as qualiﬁed with GRADE was however low.
Conclusions: Low-quality evidence indicates that prophylactic NPWT signiﬁcantly reduces the risk of SSIs.
Abbreviations: CINAHL=Cumulative Index to Nursing and Allied Health Literature, EMBASE=Excerpta Medica Database,
GRADE=Grading of Recommendations Assessment, Development, and Evaluation, MOOSE=meta-analysis of observational
studies in epidemiology, NPWT=negative pressure wound therapy, OR=odds ratio, pNPWT=prophylactic negative pressure
wound therapy, PRISMA=Preferred Reporting Items for Systematic Review and Meta-Analysis, RCT= randomized controlled trial,
SSI=surgical site infections, WHO=World Health Organization.
Keywords: incisional wound therapy, prevention, prophylactic negative pressure wound therapy, surgical site infection, wound
infections
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1. Introduction
Surgical site infections (SSIs) are the number one healthcare-
associated infections worldwide, with an incidence of 2% to
20%, or even higher, depending on the type of surgery and
patient characteristics.[1,2] SSI are associated with increased
morbidity, mortality, and extended hospital stay. Furthermore,
increased healthcare costs are attributable to SSI.[3]
Several perioperative preventive measures have been imple-
mented to minimize the risk of SSI, such as hand washing of the
surgical team, antibiotic prophylaxis, skin preparation, and
sterile drapes and gowns. Despite these measures healthcare
associated infections, especially SSI, remain a challenging
problem to surgeons and patients worldwide.[4]
Prophylactic (or closed incision) negative pressure wound
therapy (pNPWT) denotes the prophylactic use of negative
pressure wound therapy (NPWT) to prevent wound complica-
tions, speciﬁcally SSI. Although NPWT has been used since late
1990s for several purposes, such as open bone fractures,[5,6]
diabetic ulcers,[7] and management of the open abdomen,[8] its
prophylactic use for primarily closed incisions has only been
described a decade ago.[9]
Prophylactic NPWT consist of a hermetically sealed system
connected to a vacuum pump, which maintains negative pressure
on the wound surface. Although several studies on the working
mechanism of NPWT have been performed and reviewed,[10]
there is a lack of preclinical research regarding pNPWT. It has
been suggested that by using negative pressure dead space is
reduced, tissue proliferation is stimulated, and ﬂuids are
removed. Moreover, pNPWT could protect against micro-
organisms entering from the outside world. Prophylactic NPWT
has been suggested as a promising application to reduce SSIs and
other wound complications. A few previous reviews have been
published[11,12] using different methodology, for example,
combining randomized controlled trials (RCTs) and observa-
tional studies into one analysis. Not many studies on clean-
contaminated surgery were included, and none of the previous
systematic reviews qualiﬁed evidence using Grading of Recom-
mendations Assessment, Development, and Evaluation
(GRADE). Our aim was to systematically review the available
literature on pNPWT in terms of reducing SSI in all types of
surgery. This review was conducted as part of the development of
the Global Guidelines for prevention of SSIs commissioned by
World Health Organization in Geneva.
2. Methods
The PRISMA[13] (preferred Reporting Items for Systematic
Reviews and Meta-Analyses) and MOOSE[14] (meta-analysis
of observational studies in epidemiology) guidelines were
followed.
2.1. Search strategy and selection criteria
References for this review were identiﬁed through searches of
PubMed, EMBASE (Ovid), the Cochrane Central Register of
Controlled Trials (CENTRAL), CINAHL, and World Health
Organization for articles published from January 1990 to
October 7, 2015 by use of the terms “surgical site infection,”
“negative pressure wound therapy,” and “surgical procedure.”
The complete search is included in appendix A, http://links.lww.
com/MD/B234. Two authors (FdV and EW) independently
screened all titles and abstracts. RCTs or observational studies
comparing pNPWT with conventional wound dressings in adult
patients were included. We chose to include observational
studies, because previous systematic reviews did not identify any
RCTs in potentially contaminated surgery. Studies had to, at
least, report on SSIs or wound infections, either as primary or
secondary outcome. Studies using NPWT on an open wound or
split skin graft were excluded. We had no language restrictions.
References of the included studies were screened for other
relevant studies. We only considered full text published studies.
2.2. Data extraction
Study characteristics including year of publication, number of
patients, types of surgical procedures, duration of prophylactic
NPWT, amount of negative pressure, details on standard
dressings, and outcome were retrieved from the text.
2.3. Quality assessment
Quality of the included studies was assessed with the Cochrane
Collaboration’s tool for assessing risk of bias[15] for RCTs and
with the New-Castle Ottawa scale[16] for observational studies.
The GRADE methodology was used to assess the quality of the
body of retrieved evidence (GRADEpro, Version 20. McMaster
University, 2014).
2.4. Data synthesis and analysis
Meta-analyses were performed with a random effect model in
Review Manager (RevMan), Version 5.3. Copenhagen: The
Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
Heterogeneity of the included studies was evaluated by calculating
the I2 statistic. Subgroup meta-analyses stratiﬁed by wound
class and type of surgery were performed subsequently.
2.5. Ethical approval
Ethical approval was not necessary due to the study design.
3. Results
Of the 1238 articles initially identiﬁed by the search, we selected
49 for a full text review (Fig. 1). Thirty articles were excluded; 14
studies were not relevant, 14 did not describe pNPWT, 1[17] did
not report on SSIs as outcome, and 2 studies reported on an
overlapping cohort[18,19] and were, therefore, combined for the
purpose of analysis. Finally, 19 articles describing 21 studies
were included. One article described 2 separate randomized
controlled trials within one report,[9] which were assessed
and analyzed separately in present meta-analysis. In another
observational study, 2 patient populations (breast and
colorectal surgery) were assessed and analyzed separately.[20]
These were 6 RCTs reported in 5 articles (including 562 patients)
and 15 observational studies reported in 14 articles (including
4560 patients).
3.1. Study characteristics
We found 6 RCTs,[6,9,21–23] 3 prospective observational
studies,[19,20,24] 10 retrospective observational studies,[25–34]
and 1 article[35] with both retro- and prospective data. In the
observational studies, the use of pNPWT was based on the
surgeons decision in 6 studies[19,25,27,30,32,33] and based on time
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(before-after) in 8 studies.[24,25,28,29,31,34–36] The evidence table
with more detailed information is in Table 1.
We found 9 studies on abdominal surgery[19,26–28,36] of which
4 involved ventral hernia repair procedures,[29,30,32,34] 6 studies
in orthopaedic or trauma surgery[9,21,22,25,33] 2 studies in cardiac
surgery,[24,35] and 2 studies in vascular surgery. One study[20]
included both abdominal and breast surgery. Apart from 1 study,
all RCTs were performed in clean surgery. The other study
involved patients of which more than 90% underwent lower
extremity amputation due to chronic wounds. The negative
pressure devices were set between 75 and 125mm Hg, and the
length of negative pressure varied between 24hours till 7 days
postoperative. Either dry gauze, conventional-, occlusive-, or
absorbent dressings were used in the control group.
The deﬁnition for SSI differed between studies. Nine studies
used the deﬁnition described by the Centers for Disease Control
and Prevention,[37] 4 used clinical signs and symptoms as a
criteria for SSI, and 2 other, both retrospective studies, scored for
SSI in case any treatment was necessary. Follow-up time varied
considerably but was, if reported, always at least 30 days. The
risk of bias scoring is provided in appendix A, http://links.lww.
com/MD/B234.
3.2. Prophylactic negative pressure wound therapy versus
conventional wound dressings
The meta-analysis of 6 RCTs[6,9,21–23] showed a signiﬁcant
beneﬁt of pNPWT over conventional dressings in regard to
reducing the risk of SSI (odds ratio [OR], 0.56; 95% conﬁdence
interval [CI], 0.32–0.96, I2 0%). The meta-analysis of 15
observational studies[19,20,24–35] showed a signiﬁcant beneﬁt of
pNPWT over conventional dressings in regard to reducing the
risk of SSI (OR, 0.30; 95% CI, 0.22–0.42, I2 18%) (Figs. 2 and
3). The funnel plots of both meta-analyses are included in
Articles identified through literature search
  n = 2144
Medline n = 1114
EMBASE n = 890
CENTRAL n = 9
CINAHL n = 129
WHO n = 2
Citations identified through other sources (e.g. 
reference lists) n = 3
Total after removal of duplicates n = 1238
Full-text articles assessed for eligibility 
n = 49
Excluded based on titles and abstracts 
n = 1191
Total articles included n = 19 (21 studies)
6 RCTS
15 observational studies
Articles excluded based on full-text n=30
Not relevant n=14
No closed incision pNPWT n=14
No outcome of SSI n=1
Report on same cohort as included study n=1
Figure 1. Flow-chart of the systematic review.
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Appendix B, http://links.lww.com/MD/B234. They did not reveal
clear indications of publication bias.
3.3. Subgroup comparisons
When we stratiﬁed observational studies by wound class the
meta-analysis of 8 clean-contaminated or contaminated obser-
vational studies[19,20,26–28,30,32,34] showed a signiﬁcant beneﬁt of
pNPWT over conventional dressings (OR, 0.29; 95% CI,
0.17–0.50) as did the meta-analysis of 8 clean observational
studies[19,20,24,25,29,31,33–35] (OR, 0.27; 95% CI, 0.17–0.42)
(Fig. 4). Two studies[20,34] were used in both aforementioned
subgroup comparisons as 1 study reported separate results on
both clean and clean-contaminated patients and the other study
was included as 2 separate cohort studies in our analysis. When
we stratiﬁed by type of surgery meta-analysis of 4 RCTs in
orthopaedic/trauma surgery did not show signiﬁcant beneﬁt nor
harm in regards to reducing the risk of SSI (OR, 0.58; 95% CI,
0.32–1.07). There was only a single RCT in vascular surgery
which did not show a signiﬁcant reduction in SSI, whereas an
observational study in vascular surgery did (OR, 0.47; 95% CI,
0.10–2.11 and OR, 0.14; 95% CI, 0.04–0.51, respectively). The
meta-analysis of 9 observational studies in abdominal surgery
including, besides the 1 study in vascular surgery, ventral hernia
repair showed a signiﬁcant beneﬁt of pNPWT over conventional
dressings in regards to reducing SSI (OR, 0.31; 95% CI,
0.19–0.49) as did 2 studies in cardiac surgery (OR, 0.29; 95%CI,
0.12–0.69), and 1 observational study in breast surgery (OR,
0.15; 95% CI: 0.03–0.81). Two observational studies in
orthopaedic/trauma surgery showed no signiﬁcant beneﬁt for
pNPWT over conventional dressings (OR, 0.42; 95% CI,
0.13–1.40). These additional subgroup meta-analyses are
included in Appendix C, http://links.lww.com/MD/B234.
3.4. GRADE
Overall evidence was qualiﬁed using GRADE for both RCTs and
observational studies. Overall, low quality of evidence shows that
pNPWT may have beneﬁt when compared to conventional
postoperative wound dressings in reducing the risk of SSI. The
level of evidence for RCTs was downgraded due to the lack of
blinding in outcome assessment in most of the studies and
because the optimal information size was not met. The GRADE
tables are in Tables 2 and 3.
4. Discussion
In this systematic review, a signiﬁcant beneﬁt was found for
pNPWT over conventional wound dressings in terms of reducing
SSIs in both RCTs and observational studies (OR, 0.56; 95% CI,
0.32–0.96 and OR, 0.30; 95% CI, 0.22–0.42, respectively). This
translates into lowering the SSI rate from 140 to 83 (49–135) per
1000 patients and from 106 to 34 (25–47) per 1000 patients,
respectively. These results were consistent in both clean and
clean-contaminated procedures and in different types of surgery.
However, in stratiﬁed analyses, we found no signiﬁcant beneﬁt
for orthopaedic/trauma surgery in both observational and
randomized studies, and conﬂicting data for vascular surgery.
Overall quality of evidence, as qualiﬁed by GRADE, was low.
This means that further research is very likely to have an
important impact on our conﬁdence in the estimate of effect and
is likely to change the estimate.[38]St
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Figure 4. Stratiﬁcation by wound class (all observational studies).
Figure 3. Overall effect of pNPWT on SSI compared to conventional wound dressings in observational studies. pNPWT=prophylactic negative pressure wound
therapy, SSI=surgical site infections.
Figure 2. Overall effect of pNPWT on SSI compared to conventional wound dressings in RCTs. pNPWT=prophylactic negative pressure wound therapy, RCT=
randomized controlled trial, SSI=surgical site infections.
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Although pNPWT was introduced only 10 years ago, the use
of pNPWT has rapidly spread and this application is nowadays
used for a variety of wounds. The number of RCTs identiﬁed in
our literature search is limited and all but 1 RCTwere performed
following clean, primarily orthopaedic or trauma procedures.
We decided to include controlled observational studies because
the novelty of the technique is only now generating interest in
more accurate RCTs. Moreover, by including observational
studies, we included data on potentially contaminated surgery
next to clean surgery. In ourmeta-analyses, we found pNPWT to
be more effective in observational studies (OR, 0.30) than RCTs
(OR, 0.56). This is expected due to the bias in observational
studies where surgeon perceptions, often quite accurate,
determine allocation.[39] We note that several observational
studies included in our review reported a high incidence of SSI in
the control group. Most of these studies were performed in
abdominal surgery or (complex) ventral hernia repair, surgical
procedures prone to SSI.[40,41] The inherent selection of high risk
wounds prevents extrapolating these results to all types of
surgery.
This is the ﬁrst systematic review andmeta-analysis performing
separate analyses for observational studies and RCTs and
qualifying evidence by the use of GRADE. One previous meta-
analysis was performed by Semsarzadeh et al,[12] but they
combined observational studies and RCTs in their analyses.
Additionally, we included 6 recently published studies. Another
more recent meta-analysis[11] only included RCTs, but they
included unpublished data and studies not reporting on the
incidence of SSI but only on seroma.
Some limitationsof thepresent studyneed tobe addressed. In the
ﬁrst place, we used (retrospective) observational studies as well as
RCTs. Observational studies are well known to involve selection
bias and publication bias, as positive results may be more likely to
be published than negative results.[39] Another limitation was the
inclusion of only a small number of patients in most studies,
and therefore large conﬁdence intervals within each study. This
makes it difﬁcult to estimate the real effect. Although statistical
heterogeneity was low (I2 0% for RCTs and I2 18% for
observational studies), there was variation in protocols used in
the included studies in important variables, such as the amount of
negative pressure, the duration of pNPWT, and the control
dressing. There was also variation in the deﬁnition of a SSI used
among the included studies and a lack of baseline characteristics
inﬂuencing the risk of SSI (eg, diabetes or immunosuppression).
Therefore, clinical heterogeneity might be higher than statistical
heterogeneity reveals.
Although the potential of pNPWT to reduce the incidence of SSI
has been shown, limited studies on cost effectiveness are available.
The price of pNPWT varies between $15/d[42] and $495/wk[43]
dependingona self-madeor commercial application. Three studies
on cost effectiveness in a gynecologic population have been
performed.[44–46] Their results show a potential for pNPWT to be
cost effective, especially inpatient groupswithhigh riskof SSI, such
as clean-contaminated operations, or operations performed upon
patients with intrinsic risk factors, such as obesity, diabetes, or
immunosuppressive medication.
This brings us to the question how useful GRADE is when
dealing with new technologies, and even more speciﬁc, a new
application for a relatively new technology. It remains to be seen
whether a signiﬁcant beneﬁt found in meta-analysis but qualiﬁed
as low (due to high risk of bias and patient selection) is enough to
promote its widespread use. On the other hand, surgeons dealing
with difﬁcult wounds might want to use every option they have to
reduce wound infections.
Conclusive data on cost effectiveness are lacking, but pNPWT
is most likely to be cost effective in procedures at high risk for SSI
due to patients’ or operative characteristics. Before widespread
use of this application in low-risk as well as high-risk wounds,
randomized controlled trials are required to identify the group of
patients in whom pNPWT is cost effective. Moreover, the
inﬂuence of pNPWT on other important wound complications,
such as wound dehiscence or seroma, has been shown but needs
to be studied more speciﬁcally in prospective studies.
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